Skip to main content
Caplight Logo









Lithea AB

Lithea AB

Private
LundHealthcare & Life Scienceshttps://www.lithea-pharma.com/

Last Round

Grant

Apr 8, 2026

Total Funding Raised

$989,000

Company Overview

Lithea AB is a Swedish pharmatech company that develops a bone mineral-based platform for the local delivery of cancer drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug delivery systemintratumoral deliverypharmatechbiotechosteosarcoma treatmentbiocompatible materialssustained releasechemotherapy deliverymedical devicedrug-device combinationbone mineral platformlocal chemotherapyorphan drugsmart drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lithea AB Comparables

Compare Lithea AB with similar companies based on industry and business-model similarity.

Lithea AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PanTher Therapeutics
78%
Zetagen Therapeutics
78%
Atlanthera
78%

Lithea AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 8, 2026
SeedOct 24, 2025
GrantOct 13, 2025

Key People

Founding team and executive leadership

BSBA MB BChir Dr Mathias Lidgren

Chief Medical Officer, Executive Board Member

Executive Team

Lithea AB Investors

Notable investors and investment history

Lithea AB investors
InvestorRounds
VinnovaGrant
EU Eureka InnowwideGrant

Lithea AB Filings

Explore SEC and related filing metadata, where available.

Lithea AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lithea AB's valuation, stock price, and market status.

Is Lithea AB a public or private company?

Lithea AB is a private company.

What is the current stock price of Lithea AB?

Lithea AB is a private company with no public stock price. No recent secondary market data is available.

How much is Lithea AB worth (valuation)?

Valuation information for Lithea AB is not publicly available.

Can I buy Lithea AB stock?

Lithea AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lithea AB's last funding round?

Lithea AB's most recent funding round was Grant on April 8, 2026.

Who are the main investors in Lithea AB?

Key investors in Lithea AB include Vinnova, EU Eureka Innowwide.

Will Lithea AB IPO soon?

No public IPO plans have been announced for Lithea AB.

How can I track Lithea AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lithea AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLund
Employee Range4
Year Founded2021
Last FundingApr 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?